awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28484913-212A9E0A-B757-42E2-9127-671B199A2067
Q28484913-212A9E0A-B757-42E2-9127-671B199A2067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28484913-212A9E0A-B757-42E2-9127-671B199A2067
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors
P2860
Q28484913-212A9E0A-B757-42E2-9127-671B199A2067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28484913-212A9E0A-B757-42E2-9127-671B199A2067
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
272345c87d06e7454eb633f0026565be690602fa
P2860
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.